_PRIVATE_LIMITED.webp)
Cure Medicines (India) Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 27-07-2024
- Paid Up Capital ₹ 3.00 M
as on 27-07-2024
- Company Age 21 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.00 Cr
as on 27-07-2024
- Satisfied Charges ₹ 1.50 Cr
as on 27-07-2024
- Revenue -42.32%
(FY 2023)
- Profit -510.92%
(FY 2023)
- Ebitda -292.70%
(FY 2023)
- Net Worth -26.56%
(FY 2023)
- Total Assets 25.89%
(FY 2023)
About Cure Medicines (India)
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 3.00 M.
The company currently has active open charges totaling ₹8.00 Cr. The company has closed loans amounting to ₹1.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
Shyam Bothikar and Ulhas Puranik serve as directors at the Company.
- CIN/LLPIN
U24230PN2003PTC140047
- Company No.
140047
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Mar 2003
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Cure Medicines (India)?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shyam Bothikar  | Director | 15-Mar-2007 | Current |
| Ulhas Puranik | Director | 15-Mar-2007 | Current |
Financial Performance and Corporate Structure Insights of Cure Medicines (India).
Cure Medicines (India) Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 42.32% decrease. The company also saw a substantial fall in profitability, with a 510.92% decrease in profit. The company's net worth observed a substantial decline by a decrease of 26.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cure Medicines (India)?
In 2023, Cure Medicines (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Cure Laboratories Private LimitedActive 15 years 5 monthsShyam Bothikar and Ulhas Puranik are mutual person
Cure Exports Private LimitedActive 17 years 16 daysShyam Bothikar and Ulhas Puranik are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 30 Mar 2024 | ₹5.00 Cr | Open |
Others Creation Date: 11 Nov 2022 | ₹8.50 M | Open |
Others Creation Date: 15 Oct 2022 | ₹1.50 M | Open |
How Many Employees Work at Cure Medicines (India)?
Cure Medicines (India) has a workforce of 42 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cure Medicines (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cure Medicines (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
